INTERSOLV INC
424B3, 1996-03-19
PREPACKAGED SOFTWARE
Previous: PHP HEALTHCARE CORP, 424B2, 1996-03-19
Next: TELEMUNDO GROUP INC, SC 13D/A, 1996-03-19



          The Date of this Prospectus is March 19, 1996
                                          Registration # 33-31143
                                                   Rule 424(b)(3)


                         INTERSOLV, INC.
                3,583,585 Shares of Common Stock

      The  Common  Stock  of Intersolv, Inc.  (the  "Company"  or
"Intersolv"),  par  value $0.01 per share (the  "Common  Stock"),
offered hereby is held by the Selling Securityholders (as defined
herein)  who may from time to time offer for sale such shares  of
Common  Stock.  See "Selling Securityholders."  The Company  will
not   receive   any  proceeds  from  the  sale  by  the   Selling
Securityholders of the Common Stock.

      The  Common  Stock is listed on the NASDAQ National  Market
under  the  symbol "ISLI."  On March 18, 1996, the last  reported
sale  price  of the Common Stock reported on the NASDAQ  National
Market was $11.375 per share.  See "Price Range of Common Stock."

                 _______________________________

       See  "Risk  Factors"  beginning  on  page  5  for  certain
information that should be considered by prospective investors.
                 _______________________________

THESE  SECURITIES  HAVE NOT BEEN APPROVED OR DISAPPROVED  BY  THE
SECURITIES  AND  EXCHANGE  COMMISSION  OR  ANY  STATE  SECURITIES
COMMISSION NOR HAS THE SECURITIES AND EXCHANGE COMMISSION OR  ANY
STATE  SECURITIES COMMISSION PASSED UPON THE ACCURACY OR ADEQUACY
OF  THIS  PROSPECTUS.  ANY REPRESENTATION TO THE  CONTRARY  IS  A
CRIMINAL OFFENSE.

                       ____________________


      Any  or all of the Common Stock offered hereby may be  sold
from   time   to  time  to  purchasers  directly  by  a   Selling
Securityholder.  Alternatively, a Selling Securityholder may from
time  to  time offer any or all of the Common Stock to or through
underwriters, dealers, brokers or other agents.  In addition, the
Selling Securityholders and/or any underwriter, broker, dealer or
other  agent may engage in hedging transactions with  respect  to
the  Common Stock.  In connection with such transactions,  shares
of  Common Stock offered hereby may be sold or delivered to cover
any  short  positions  resulting  from  such  transactions.   The
Company  will  pay  the  expenses of this offering  estimated  at
$37,000.   The Common Stock offered hereby may be sold from  time
to  time  in one or more transactions at a fixed offering  price,
which may be changed, or at varying prices determined at the time
of  sale or at negotiated prices.  Such prices will be determined
by  a  Selling Securityholder or by agreement between  a  Selling
Securityholder  and its underwriters, dealers, brokers  or  other
agents.

      Any  underwriters, dealers, brokers or other agents  to  or
through  whom  Common Stock offered hereby is  sold  may  receive
compensation  in the form of underwriting discounts, concessions,
commissions   or  fees  from  a  Selling  Securityholder   and/or
purchasers of Common Stock for whom they may act.  In addition, a
Selling   Securityholder  and  any  such  underwriters,  dealers,
brokers  or  other agents as agent or to whom they  may  sell  as
principal,   or   both  (which  compensation  to   a   particular
underwriter, broker, dealer or other agent might be in excess  of
customary commissions) may be deemed to be underwriters under the
Securities  Act, and any profits on the sale of Common  Stock  by
them  and  any discounts, commissions or concessions received  by
any  of  such persons may be deemed to be underwriting  discounts
and  commissions  under the Securities Act.   Those  who  act  as
underwriter, broker, dealer or other agent in connection with the
sale   of  the  Common  Stock  will  be  selected  by  a  Selling
Securityholder and may have other business relationships with the
Company and its subsidiaries or affiliates in the ordinary course
of business.  The Company cannot presently estimate the amount of
any  such  discounts,  commissions or concessions.   The  Company
knows   of   no   existing  arrangements  between   the   Selling
Securityholders  and  any underwriter, dealer,  broker  or  other
agent.  See "Plan of Distribution."


      No person has been authorized to give any information or to
make  any  representations other than  those  contained  in  this
Prospectus   and,   if  given  or  made,  such   information   or
representations  must  not  be  relied  upon   as   having   been
authorized.  This Prospectus does not constitute an offer to sell
or  the solicitation of an offer to buy any securities other than
the  securities to which it relates or an offer to  sell  or  the
solicitation  of  an  offer  to  buy  such  securities   in   any
circumstances  in which such offer or solicitation  is  unlawful.
Neither  the  delivery  of  this Prospectus  nor  any  sale  made
hereunder  shall, under the circumstances, create any implication
that there has been no change in the affairs of the Company since
the  date  hereof  or  thereof or that the information  contained
herein  or  therein is correct as of any time subsequent  to  the
date of such information.

     TABLE OF CONTENTS
          
                                                        Page
          Available Information                           2
          Documents Incorporated by Reference             3
          The Company                                     4
          Risk Factors                                    5
          Price Range of Common Stock                     7
          Use of Proceeds                                 7
          Selling Securityholders                         8
          Plan of Distribution                           11
          Description of Capital Stock                   12
          Legal Matters                                  13
          Experts                                        14
          
          
     AVAILABLE INFORMATION

      The Company is subject to the informational requirements of
the  Securities  Exchange Act of 1934, as amended (the  "Exchange
Act"), and the rules and regulations promulgated thereunder,  and
in accordance therewith files reports, proxy statements and other
information  with  the  Securities and Exchange  Commission  (the
"Commission").    Such  reports,  proxy  statements   and   other
information  filed by the Company with the Commission,  including
the  Registration Statement on Form S-3 of which this  Prospectus
is  a  part, may be inspected and copied at the public  reference
facilities  maintained by the Commission  at  450  Fifth  Street,
N.W.,  Washington,  D.C.  20549, and at  the  following  Regional
Offices of the Commission:  New York Regional Office, Seven World
Trade  Center,  New  York, New York 10048  and  Chicago  Regional
Office, 500 West Madison Street, Chicago, Illinois 60661.  Copies
of  such  material can also be obtained from the Public Reference
Section  of the Commission at 450 Fifth Street, N.W., Washington,
D.C.  20549, at prescribed rates.  The Common Stock is traded  in
the  over-the-counter market and is quoted in the NASDAQ National
Market.   Copies  of the Company's reports, proxy statements  and
other information filed with the Commission can also be inspected
at the offices of the National Association of Securities Dealers,
Inc. at 1735 K Street, N.W., Washington, D.C. 20006.

      The  Company  has filed with the Commission a  Registration
Statement  on  Form  S-3 (herein, together with  all  information
incorporated  by  reference therein and amendments  and  exhibits
thereto,  referred to as the "Registration Statement") under  the
Securities  Act of 1933, as amended (the "Securities Act"),  with
respect  to the securities offered hereby.  This Prospectus  does
not  contain all of the information set forth or incorporated  by
reference in the Registration Statement, certain parts  of  which
are  omitted  as  permitted by the rules and regulations  of  the
Commission.  Statements contained in this Prospectus  as  to  the
contents  of  any contract or other document are not  necessarily
complete, and in each instance reference is made to the  copy  of
such  contract  or  other document filed as  an  exhibit  to  the
Registration  Statement, each such statement being  qualified  in
all   respects  by  such  reference.   For  further   information
regarding   the  Company  and  the  securities  offered   hereby,
reference is made to the Registration Statement.
     DOCUMENTS INCORPORATED BY REFERENCE

     The following documents previously filed by the Company with
the  Commission (File No. 0-15188) pursuant to the  Exchange  Act
are  incorporated herein by this reference and are made  part  of
this Prospectus:

     (1)  The Company's Annual Report on Form 10-K for the fiscal
year  ended April 30, 1995, filed pursuant to Section 13  of  the
Exchange Act;

      (2)   The Company's Quarterly Report on Form 10-Q  for  the
quarter ended July 31, 1995, filed pursuant to Section 13 of  the
Exchange Act;

      (3)   The Company's Quarterly Report on Form 10-Q  for  the
quarter ended October 31, 1995, filed pursuant to Section  13  of
the Exchange Act;

      (4)   The Company's Quarterly Report on Form 10-Q  for  the
quarter ended January 31, 1996, filed pursuant to Section  13  of
the Exchange Act; and

      (5)   The  Company's  Current Report  on  Form  8-K,  dated
November 7, 1995 and as amended by Amendment No. 1, dated January
5, 1996, each filed pursuant to Section 13 of the Exchange Act.

      All  documents  filed by the Company  pursuant  to  Section
13(a),  13(c), 14 or 15(d) of the Exchange Act after the date  of
this  Prospectus and prior to termination of the offering of  the
Common  Stock shall be deemed to be incorporated by reference  in
this  Prospectus and to be a part hereof from the date  any  such
document  is  filed.   Any  statement  contained  in  a  document
incorporated  or  deemed to be incorporated by  reference  herein
shall  be  modified or superseded for purposes of this Prospectus
to  the  extent  that  a statement contained  herein  or  in  any
subsequently filed document which is deemed to be incorporated by
reference  herein  modifies or supersedes  such  statement.   Any
statement  so modified or superseded shall not be deemed,  except
as  so  modified  or superseded, to constitute  a  part  of  this
Prospectus.

      The  Company will provide without charge to each person  to
whom a copy of this Prospectus is delivered, upon written or oral
request,  a copy of any and all of the documents incorporated  by
reference  herein, other than exhibits to such  documents  unless
such  exhibits  are specifically incorporated by  reference  into
such  documents.  Any such request may be directed to  Intersolv,
Inc.,  Attention:  Kenneth A. Sexton, at the Company's  principal
executive  offices, which are located at 9420  Key  West  Avenue,
Rockville, Maryland  20850, telephone number (301) 838 5000

     Intersolv, APS, Excelerator, Maintenance Workbench, PVCS and
SequeLink are trademarks of Intersolv.
     THE COMPANY

      Intersolv  is  a  software  product  and  service  company,
specializing   in  open,  client/server  tools.   The   Company's
products  and  services  support a  broad  range  of  approaches,
ranging from the development of new client/server systems to  the
maintenance  of  traditional  systems.   The  Company's   product
strategy  emphasizes  an  open  architecture  which  permits  its
products to be used separately, with the Company's other products
and with software development products and approaches offered  by
other  companies.  The Company's objective is to  build  products
that  deliver  high  productivity  on  simple  projects  and  are
powerful enough to handle scalability requirements of production-
grade information systems without retooling.

      Intersolv  offers  software products and  services  in  the
following solution areas:

    Object  Oriented  ("OO") Development  -  The  Company  has
 invested   significant   resources  in   the   acquisition   and
 development  of OO application development tools.  This  product
 series  is  focused  on the needs of developers  using  the  C++
 language.   This  product series, which will be  marketed  under
 the  brand  name Allegris, is due for general release  early  in
 fiscal year 1997.

     Enterprise Client/Server Development - Intersolv also offers
 tools  for  traditional developers using the Cobol language  who
 want  to move into the client/server architecture.  These  tools
 can  be  used for rapid application development ("RAD"),  design
 driven  development  or  for maintenance  and  reuse  of  legacy
 applications.

     Data Warehousing - Intersolv products provide access to more
 than   30   database  management  systems  ("DBMS").   Offerings
 include  an  end  user query and reporting  tool  and  tools  to
 deploy  cross-platform  Open  Database  Connective  ("ODBC")  to
 compliant applications accessing multiple DBMS.

     Software Configuration Management ("SCM") - Intersolv offers
 a  comprehensive SCM product suite.  The Company's SCM offerings
 leverage  team  development on the LAN while  supporting  multi-
 operating systems and multi-tool environments.

      The  Company  markets and distributes its products  to  end
users,  line  of  business  developers,  traditional  information
system  departments, project managers and application development
executives  within corporations and independent software  vendors
worldwide.   Sales in the United States, Japan,  United  Kingdom,
Germany,  France, Belgium and Australia are made through  Company
owned  and  operated  entities which use a combination  of  field
sales  (face  to  face), telesales and third  party  distribution
channels.  The Company's direct sales effort is augmented with  a
network  of  independent software vendors, dealers,  distributors
and  value  added resellers in more than 30 countries around  the
world.

      Intersolv has expanded its operations both through internal
development  and  selected acquisition of complementary  products
and  businesses.  In October 1995, Intersolv acquired  TechGnosis
International, Inc. ("TechGnosis") in a transaction accounted for
using the "pooling-of-interests" method.

      Intersolv was incorporated under the laws of the  State  of
Delaware  in 1985, successor to the business begun in 1982.   The
Company's  principal executive offices are located  at  9420  Key
West  Avenue, Rockville, Maryland 20850, and its telephone number
at that address is (301) 838-5000.
     RISK FACTORS

     Prospective investors should carefully consider, among other
factors, the following:

      Technological  Changes.   The  software  development  tools
market  is characterized by rapid changes in technology and  user
needs.   Compatibility of the Company's products with  customers'
preferred  operating systems and database management systems  are
important  to future results of the Company.  The current  market
trend  appears to be weighted towards building client/server  and
cooperative  applications  using  a  changing  mix  of  operating
systems.   Revenue  from  the Company's  Traditional  Development
tools  area declined by 22% during the year ended April 30, 1995.
Products  in this area accounted for 35% of fiscal 1995  revenue,
and  the  Company expects demand in this area to remain  flat  or
continue  to  decline.   During  fiscal  1995,  the  decline   in
traditional development tools revenues was more than offset by  a
70%   revenue  increase  in  the  Company's  other  products  and
services.   Because of the rapidly changing market, there  is  no
assurance  that  this substantial growth will  continue.   Future
operating  results could be adversely affected  by  the  market's
acceptance  of  the Company's existing and new products  in  this
rapidly changing market.

      Competition.   The  market for the  Company's  products  is
highly  competitive.   The  Company competes  with  a  number  of
companies  that  market similar types of products.   The  Company
also   expects  to  encounter  competition  in  the  future  from
established companies and new companies that may develop products
competitive  with the Company's products.  Many of the  Company's
actual  and  potential  competitors  have  substantially  greater
financial,  marketing  and  technological  resources   than   the
Company.   Due  to  the inherently unpredictable  nature  of  the
market  in  which the Company competes, any actual  or  potential
competitor  is capable of capturing a disproportionate  share  of
the  market  in  a relatively short time frame.  Such  a  rapidly
shifting    demand   would   adversely   affect   the   Company's
profitability.

      Fluctuations  in Quarterly Performance.  Historically,  the
Company recognizes a major portion of its revenue during the last
month   of   a  fiscal  quarter  and  has  experienced  quarterly
fluctuations in revenues and earnings due to the timing of  large
orders.   The  Company  has no significant revenue  backlog,  and
substantially all of its product revenues in any quarter  results
from sales made in the quarter.  If sales are delayed and do  not
close  in  a  quarter  as  expected,  the  Company's  results  of
operations  for  that quarter would be adversely  affected.   Net
income  may  be  disproportionately affected by  a  reduction  in
revenues because a large portion of the Company's expenses do not
vary with revenues.  Historically, the Company has recognized the
largest  portion  of  its revenues and operating  income  in  the
fourth  quarter  of  its fiscal year, and the  Company  typically
experiences  lower revenues and operating income  for  the  first
quarter of a fiscal year than in the fourth quarter of the  prior
fiscal year.

      Acquisition Charges.  In the past, the Company has expanded
its  operations through selected acquisitions.  As  a  result  of
past   acquisitions,  the  Company  has  charged  earnings   with
transaction  costs and certain restructuring costs  to  integrate
the acquired businesses.  These acquisition charges have resulted
in  the  Company reporting operating losses in the fiscal quarter
and year in which the transaction was completed.

      Global  Economies.   The  Company  markets  and  sells  its
products through its own sales force and through third parties in
approximately 30 countries.  Consequently, the Company's  results
are affected by changes in global economies and currency exchange
rates.

      Third  Party Sales Channels.  In addition to the  Company's
own  marketing  organization, the Company  markets  its  products
through  a  global network of other independent software  vendors
(ISVs),   value-added   resellers   (VARs)   and   dealers    and
distributors.  Through third party alliances, the Company enables
selected ISVs to embed and sell certain Intersolv technologies in
their own products, for which the Company receives royalties.  In
addition,  VARs,  dealers and distributors resell  the  Company's
products  in  markets which the Company cannot  cost  effectively
reach  on  a direct basis.  The success of these sales  channels,
and  thus  the  amount of royalties the Company may  receive,  is
dependent  on the financial condition and marketing effectiveness
of  these  third  parties,  which  the  Company  cannot  directly
control.

      Dependence  on  Key Personnel.  Competition  for  qualified
personnel  in  the  software industry  is  intense.   The  future
success of the Company will depend on its ability to attract  and
retain  key  employees.  The failure to attract or  the  loss  of
these individuals could have an adverse effect on the Company.

      Possible  Volatility of Stock Price.  The market price  for
the  Common Stock has been highly volatile over the past  several
years,  and  the  market  price may  be  subject  to  significant
volatility  in  the  future, particularly on a  quarterly  basis.
Factors  such  as  fluctuations  in  quarterly  performance,  the
announcement  of  technological  innovations  or  new  commercial
products  by  the Company or its competitors, as well  as  market
conditions  in  the computer software or hardware industries  and
the  condition of the economy in general, may have a  significant
impact  on the market price of the Common Stock. In addition,  in
recent  years  the stock market has experienced large  price  and
volume  fluctuations,  which often have  been  unrelated  to  the
operating performance of specific companies or market sectors.

      Effect  of  Delaware  Law and Certain  Charter  Provisions.
Certain   provisions  of  Delaware  law  and  of  the   Company's
Certificate of Incorporation could have the effect of  making  it
more difficult for a third party to acquire, or of discouraging a
third  party from attempting to acquire, control of the  Company.
Such  provisions  could  limit the price that  certain  investors
might be willing to pay in the future for shares of Common Stock.
Certain  of  these  provisions could make it more  difficult  for
stockholders to effect certain corporate actions and  could  also
have the effect of delaying or preventing a change in control  of
the Company.  See "Description of Capital Stock."

      Forward  Looking  Statements.   Prospective  investors  are
cautioned  that the statements in this Prospectus  that  are  not
descriptions   of   historical  facts  may  be  forward   looking
statements  that are subject to risks and uncertainties.   Actual
results  could differ materially from those currently anticipated
due  to  a  number  of factors, including those identified  under
"Risk  Factors"  and  elsewhere in this Prospectus  or  documents
incorporated by reference herein.

     PRICE RANGE OF COMMON STOCK

     The Common Stock is traded in the over-the-counter market on
the   NASDAQ  National  Market  under  the  symbol  "ISLI."   The
following  table  sets  forth, for  the  Company's  fiscal  years
indicated, the high and low last sale prices of the Common  Stock
as reported by the NASDAQ National Market.



                                      High          Low
1995
     First Quarter                    8.50          4.75
     Second Quarter                  10.00          4.75
     Third Quarter                   13.25          7.75
     Fourth Quarter                  15.50          9.75

1996

     First Quarter                    26.20          14.00
     Second Quarter                   25.37          14.50
     Third Quarter                    17.20           8.75
     Fourth Quarter 
       (through March 18, 1996)       14.37           9.62
                                   
     On January 31, 1996, there were approximately 287 holders of
record  of  the  Common  Stock.   See  the  cover  page  of  this
Prospectus for the last sales price of the Common Stock  reported
on the NASDAQ National Market as of a recent date.

     USE OF PROCEEDS

      The  sale  of the Common Stock offered hereby  is  for  the
account of the Selling Securityholders.  Accordingly, the Company
will not receive any of the proceeds from the sale by the Selling
Securityholders of the Common Stock.


     SELLING SECURITYHOLDERS

      The  Common Stock offered by this Prospectus was  initially
issued by the Company to certain shareholders on October 23, 1995
in  connection  with  the acquisition of TechGnosis.   The  table
below  sets forth information regarding the beneficial  ownership
of  the Common Stock by the Selling Securityholders as of January
31,  1996  and  as adjusted to reflect the sale of  Common  Stock
offered hereby.  For purposes of the following table, a person is
deemed to have "beneficial ownership" of any shares as of a given
date  which such person has the right to acquire within  60  days
after such date.

                       Shares Owned     Maximum Shares      Maximum Shares 
                   Before the Offering  Being Offered Owned After the Offering

Name               Number      Percent                     Number    Percent

Furman Selz SBIC L.P.(1)       
                 1,062,379       5.17%       1,062,379        0          0
BMI                478,121       2.44          478,121        0          0
Marc      Van     Rompaey(2)        
                   323,077       1.65          323,077        0          0
Walter      Resseler               
                   167,844       0.86          167,844        0          0
Sofinnova Capital II FCPR       
                   154,500       0.79          154,500        0          0
Parnib Deelnemingen BV        
                   120,001       0.61          120,001        0          0
Jean-Claude Deschamps(3)         
                   119,102       0.61          119,102        0          0
Sofinnova Ventures III L.P.       
                   103,000       0.53          103,000        0          0
TEG Holding BV     101,912       0.52          101,912        0          0
Johan  Vets         81,077       0.41           81,077        0          0
Andre Van den Bogaert(4)       
                    74,033       0.38           74,033        0          0
Karel De Gucht(5)   65,101       0.33           65,101        0          0
Anne-Lore Resseler  59,855       0.31           59,855        0          0
Sander d'Heer       55,269       0.28           55,269        0          0
Edmund Hajim(6)     50,683       0.26           50,683        0          0
William Sullivan    49,954       0.26           49,954        0          0
D.I.S. NV           43,054       0.22           43,054        0          0
Hugo Ceusters       35,866       0.18           35,866        0          0
STC NV              34,608       0.18           34,608        0          0
Theo Heselmans      32,970       0.17           32,970        0          0
GAIA                22,660       0.12           22,660        0          0
Manu Goossens       20,600       0.11           20,600        0          0
Marc Surinx         20,600       0.11           20,600        0          0
Peter Goossens      16,850       0.09           16,850        0          0
Roger Ghijs         14,574       0.07           14,574        0          0
Intervent NV        14,275       0.07           14,275        0          0
Jenny Van De Put    14,108       0.07           14,108        0          0
Terrence Quinn(7)   13,204       0.07           13,204        0          0
Clear Invest        12,745       0.07           12,745        0          0
Carl Moons          12,300       0.06           12,300        0          0
Etienne Cooreman    12,112       0.06           12,112        0          0
Michiel Carpentier  12,073       0.06           12,073        0          0
Marc Shinbrood      11,165       0.06           11,165        0          0
Jozef Colebunders   11,021       0.06           11,021        0          0
Daniel Goovaerts    10,300       0.05           10,300        0          0
Sargefi SA           9,286       0.05            9,286        0          0
Jan Detremmerie      8,691       0.04            8,691        0          0
Rolf Vets            8,652       0.04            8,652        0          0
Jef Haeverans        7,931       0.04            7,931        0          0
Michael Torto        7,725       0.04            7,725        0          0
Andrew Mills         7,551       0.04            7,551        0          0
Richard Taylor       7,551       0.04            7,551        0          0
Michel Ducourau      7,308       0.04            7,308        0          0
Henri Lagrasse       6,155       0.03            6,155        0          0
Jan Van Riel         5,947       0.03            5,947        0          0
A. Cools             5,191       0.03            5,191        0          0
Etienne Schroyen     5,191       0.03            5,191        0          0
Marc Borgers         4,686       0.02            4,686        0          0
Eddy Aerts           4,379       0.02            4,379        0          0
James O'Schaughessy  4,120       0.02            4,120        0          0
Luc Schets           4,120       0.02            4,120        0          0
Emil Ansarov         3,922       0.02            3,922        0          0
Joseph C. Tricomi    3,780       0.02            3,780        0          0
Carl Thuysbaert      3,044       0.02            3,044        0          0
Pascal Surinx        2,575       0.01            2,575        0          0
Roger De Cadt        2,422       0.01            2,422        0          0
Koenraad Meuleman    2,266       0.01            2,266        0          0
Dirk Dierickx        2,259       0.01            2,259        0          0
Arthur Sarno         2,179       0.01            2,179        0          0
Bud  Enright         2,060       0.01            2,060        0          0
Cesar  Medina        2,060       0.01            2,060        0          0
Filip Vandenbussche  2,060       0.01            2,060        0          0
Frederic Dalle       2,060       0.01            2,060        0          0
Jo  Van Hoey         2,060       0.01            2,060        0          0
Stephen Nelson       2,060       0.01            2,060        0          0
Bart Ghesquiere      1,740       0.01            1,740        0          0
Guido Cooreman       1,730       0.01            1,730        0          0
Patrick Smits        1,730       0.01            1,730        0          0
Jan Bruyndonckx      1,588       0.01            1,588        0          0
Margareta Horemans   1,345       0.01            1,345        0          0
Peter Preston        1,322       0.01            1,322        0          0
Erik  Janssens         994       0.01              994        0          0
Marc  De  Roover       721       0.00              721        0          0
Denis  Gijsemans       447       0.00              447        0          0
Johan Coppieters       422       0.00              422        0          0
James  McCarthy        412       0.00              412        0          0
Geoff   Webb           339       0.00              339        0          0
David  Grietens        113       0.00              113        0          0
Ellen  Batens          103       0.00              103        0          0
Jennifer  Taylor       103       0.00              103        0          0
Barbara  Polszak        51       0.00               51        0          0
Guy   Marceaux          41       0.00               41        0          0
Bertrand   Lepeuple     20       0.00               20        0          0
Carl   Blakeley         20       0.00               20        0          0
Christine  Dunbar       20       0.00               20        0          0
Stephane  Faubert       20       0.00               20        0          0
Virginie Lagrasse       20       0.00               20        0          0

           TOTAL 3,583,585      17.41%       3,583,585        0          0



      Because a Selling Securityholder may offer by  this
Prospectus all or some part of the Common Stock which  it
holds, no estimate can be given as of the date hereof  as
to  the amount of Common Stock actually to be offered for
sale  by a Selling Securityholder or as to the amount  of
Common   Stock   that   will  be  held   by   a   Selling
Securityholder  upon the termination  of  such  offering.
See "Plan of Distribution."

____________________________________

(1)       Includes  975,859  shares  issuable  upon   the
conversion of convertible debt.
(2)       Includes   8,804  shares  issuable   upon   the
conversion of convertible debt.
(3)       Includes   3,961  shares  issuable   upon   the
conversion of convertible debt.
(4)       Includes   1,320  shares  issuable   upon   the
conversion of convertible debt.
(5)       Includes   8,802  shares  issuable   upon   the
conversion of convertible debt.
(6)       Includes   8,804  shares  issuable   upon   the
conversion of convertible debt.
(7)       Includes  13,204  shares  issuable   upon   the
conversion of convertible debt.
     PLAN OF DISTRIBUTION

     Any or all of the Common Stock offered hereby may be sold
from  time  to time to purchasers directly by  a  Selling
Securityholder.  Alternatively, a Selling Securityholder may from
time to time offer any or all of the Common Stock to or through
underwriters, dealers, brokers or other agents.  In addition, the
Selling Securityholders and/or any underwriter, broker, dealer or
other agent may engage in hedging transactions with respect to
the Common Stock.  In connection with such transactions, shares
of Common Stock offered hereby may be sold or delivered to cover
any short positions resulting from such transactions.  The
Company will receive no proceeds from the sale of the Common
Stock offered hereby.

     The Common Stock offered hereby may be sold from time to
time in one or more transactions at a fixed offering price, which
may be changed, or at varying prices determined at the time of
sale or at negotiated prices.  Such prices will be determined by
a Selling Securityholder or by agreement between a Selling
Securityholder and its underwriters, dealers, brokers or other
agents.

     Any underwriters, dealers, brokers or other agents to or
through whom Common Stock offered hereby is sold may receive
compensation in the form of underwriting discounts, concessions,
commissions or fees from a Selling Securityholder  and/or
purchasers of Common Stock for whom they may act as agent or to
whom they may sell as principal, or both (which compensation to a
particular underwriter, broker, dealer or other agent might be in
excess of customary commissions).  In addition, a Selling
Securityholder and any such underwriters, dealers, brokers or
other  agents may be deemed to be underwriters under  the
Securities Act, and any profits on the sale of Common Stock by
them and any discounts, commissions or concessions received by
any of such persons may be deemed to be underwriting discounts
and commissions under the Securities Act.  Those who act as
underwriter, broker, dealer or other agent in connection with the
sale  of  the Common Stock will be selected by a  Selling
Securityholder and may have other business relationships with the
Company and its subsidiaries or affiliates in the ordinary course
of business.  The Company cannot presently estimate the amount of
any such discounts, commissions or concessions.  The Company
knows  of  no  existing arrangements between the  Selling
Securityholders and any underwriter, dealer, broker or other
agent.

     At any time a particular offer of Common Stock is made by a
Selling Securityholder, if required, a Prospectus Supplement will
be distributed which will set forth the identity of, and certain
information relating to, such Selling Securityholder, the
aggregate amounts of Common Stock being offered and the terms of
the offering, including the name or names of any underwriters,
dealers, brokers or other agents, any discounts, commissions and
other  items constituting compensation from such  Selling
Securityholder and any discounts, commissions or concessions
allowed or reallowed or paid to dealers.  Such Prospectus
Supplement and, if necessary, a post-effective amendment to the
Registration Statement of which this Prospectus is a part will be
filed with the Commission to reflect the disclosure of additional
information with respect to the distribution of the Common Stock.

     The Registration Rights Agreement (the "Registration Rights
Agreement"), dated as of October 23, 1995, by and among the
Company and certain shareholders provides that the Company will
indemnify  the  Selling Securityholders  against  certain
liabilities, including liabilities under the Securities Act.  The
Registration  Rights  Agreement  also  provides  for  the
indemnification of the Company by the Selling Securityholders for
certain liabilities, including liabilities under the Securities
Act.  In addition, under the Registration Rights Agreement, the
Company's  obligation to indemnify extends to  those  who
participate  in the distribution of the Common  Stock  as
underwriters for the Selling Securityholders.  Also pursuant to
the Registration Rights Agreement, the Company has agreed to pay
substantially all fees and expenses incident to the preparation,
filing, amending and supplementing of the Registration Statement
of  which  this Prospectus is a part and any registration
statements or qualifying documents filed under any  state
securities laws.

      To comply with certain states' securities laws,  if
applicable, the Common Stock offered hereby may be sold in such
states only through brokers or dealers.  In addition, in certain
states the Common Stock may not be sold unless it has been
registered or qualified for sale in such state or an exemption
from registration or qualification is available and complied
with.


     DESCRIPTION OF CAPITAL STOCK

      The Company's authorized capital stock consists  of
50,000,000 shares of Common Stock, $0.01 par value and 3,000,000
shares of Preferred Stock, $0.10 par value ("Preferred Stock").
As of January 31, 1996, there were 19,566,022 shares of Common
Stock outstanding and held of record by 287 stockholders,
excluding the shares of Common Stock issuable upon conversion the
convertible notes.  The shares outstanding exclude 1,020,756
shares of Common Stock reserved for issuance pursuant  to
Convertible Notes assumed by the Company in connection with the
acquisition of TechGnosis.  All of the outstanding shares of
Common Stock are, and the shares offered hereby will be, when
delivered  and paid for, fully paid, validly  issued  and
nonassessable.

Common Stock

     Holders of shares of Common Stock are entitled to one vote
per share on all matters to be voted on by stockholders and are
entitled to receive such dividends, if any, as may bc declared
from time to time by the Board of Directors ("Board") from funds
legally available therefor.  Upon liquidation or dissolution of
the Company, the holders of Common Stock are entitled to receive
all assets available for distribution to the stockholders,
subject to any preferential rights of the holders of Preferred
Stock.  Holders of Common Stock have no preemptive or other
subscription rights.  There are no conversion  rights  or
redemption or sinking fund provisions with respect to Common
Stock.

     The Transfer Agent and Registrar for the Common Stock is the
First National Bank of Boston.

Preferred Stock

     The Board may, without further action by the stockholders,
authorize the issuance of Preferred Stock in one or more series
and fix the rights, preferences and privileges of Preferred
Stock, including the dividend rights, dividend rate, conversion
rights,  voting  rights, rights and terms of  redemption,
liquidation preferences and sinking fund terms of Preferred Stock
of  any class or series. No shares of Preferred Stock are
outstanding.  The issuance of Preferred Stock with voting and
conversion rights may adversely affect the voting power of the
holders of Common Stock, including the loss of voting control to
others.  Further, the issuance of Preferred Stock could have the
effect of making it more difficult for a third party to acquire,
or of discouraging a third company from attempting to obtain,
control of the Company.  The Company has no current plan to issue
any shares of Preferred Stock, except as may be required under
the Company's Shareholder Rights Plan.

Shareholder Rights Plan

     On August 18, 1989, the Board adopted a Shareholder Rights
Plan  (the  "Rights Plan").  Under the Rights Plan,  each
stockholder of record has received, and upon future issuances of
shares of Common Stock recipients generally will receive, one
right (a "Right") for each share of Common Stock owned or
received, respectively.  Rights trade with the shares of Common
Stock and do not trade separately.  Each Right entitles the
holder thereof to purchase one one-hundredth of a share of the
Company's Series A Junior Participating Preferred Stock at an
exercise price of $40.00.  The Rights are not exercisable until a
person or group acquires beneficial ownership of 20.0% or more of
the Common Stock or announces a tender or exchange offer that
will result in such person or group owning 30.0% or more of the
Common Stock.  In addition, if any person acquires at least 25.0%
of the Common Stock (except pursuant to a tender or exchange
offer for all Common Stock at a fair price) or if a holder of at
least 20.0% of the Common Stock consolidates or merges into or
engages in certain other transactions with the Company, the
Rights will entitle all other holders of the Common Stock to
acquire, at the exercise price of the Right, shares of Common
Stock (or, in the event there is not a sufficient number of
authorized but unissued or reserved shares of Common Stock, any
combination of Common Stock, cash, property or other Company
securities) with a market value equal to twice the exercise price
of the Right.  If the Company is involved in a merger or other
business combination in which it is not the surviving corporation
or in which the Common Stock is changed or converted, or if the
Company sells or transfers at least 50.0% of its assets or
earning power, each Right will entitle its holder to acquire, at
the exercise price of the Right, shares of common stock of the
acquiring entity with a market value equal to twice the exercise
price of the Right.  Each Right is non-voting, expires on August
31, 1999, and may be redeemed at the Company's option prior to
becoming exercisable at a redemption price of $0.01 per Right.

     The Rights Plan is designed to protect stockholders in the
event of (i) an unsolicited offer to acquire the Company,
including an offer that does not treat all stockholders equally,
(ii) the acquisition in the open market of shares constituting
control of the Company without offering fair value to all the
stockholders, and (iii) other coercive takeover tactics that in
the opinion of the Board could impair its ability to represent
stockholder interests.  The Company is not aware of any present
efforts by any persons to obtain control of the Company.

     The provisions of the Rights Plan may render a takeover of
the Company more difficult or less likely to occur even though
such  takeover  may offer the Company's stockholders  the
opportunity to sell their stock at a price above the prevailing
market rate and may be favored by a majority of the stockholders.

Delaware General Corporation Law Section 203

     The Company is subject to the provisions of Section 203 of
the General Corporation Law of the State of Delaware.  In
general, Section 203 prohibits certain publicly held Delaware
corporations from engaging in a "business combination" with an
"interested stockholder" for a period of three years after the
date of the transaction in which the person or entity became an
interested stockholder, unless, among other exceptions, (i) the
business combination is approved by the Board prior to the date
the interested stockholder attained such status, or by the
holders of two-thirds of the outstanding voting stock not owned
by the interested stockholder or (ii) the interested stockholder
acquired 85% or more of the outstanding voting stock of the
Company in the transaction.  For purposes of Section 203, a
"business combination" is defined broadly to include mergers,
asset sales and other transactions resulting in a financial
benefit to the interested stockholder.  Subject to certain
exceptions, an "interested stockholder" is a person or entity
who, together with affiliates and associates, owns or within the
three immediately preceding years of a business combination did
own, 15.0% or more of the corporation's outstanding voting stock.


     LEGAL MATTERS

     The validity of the Common Stock offered hereby will be
passed upon for the Company by Arent Fox Kintner Plotkin & Kahn,
Washington, D.C.


     EXPERTS

     The consolidated balance sheets as of April 30, 1995 and
1994, and the consolidated statements of operations, changes in
stockholders' equity and cash flows for each of the three years
in the period ended April 30, 1995, incorporated by reference in
this Prospectus, have been incorporated herein in reliance on the
report of Coopers & Lybrand L.L.P. independent accountants, given
on the authority of that firm as experts in accounting and
auditing.




© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission